Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 32% ± 13% | |
mast cell | 4 studies | 18% ± 1% | |
ciliated cell | 4 studies | 25% ± 6% | |
fibroblast | 3 studies | 19% ± 1% | |
glutamatergic neuron | 3 studies | 27% ± 7% | |
dendritic cell | 3 studies | 22% ± 2% | |
intestinal crypt stem cell | 3 studies | 18% ± 2% |
Insufficient scRNA-seq data for expression of PRPS2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2642.14 | 245 / 245 | 100% | 66.20 | 501 / 502 |
stomach | 100% | 2731.91 | 359 / 359 | 100% | 93.68 | 285 / 286 |
bladder | 100% | 2123.33 | 21 / 21 | 100% | 89.62 | 502 / 504 |
intestine | 100% | 2673.87 | 964 / 966 | 100% | 98.24 | 525 / 527 |
uterus | 100% | 2921.78 | 170 / 170 | 99% | 109.32 | 456 / 459 |
breast | 100% | 1238.22 | 459 / 459 | 99% | 78.85 | 1109 / 1118 |
esophagus | 100% | 1332.44 | 1441 / 1445 | 99% | 65.70 | 182 / 183 |
ovary | 100% | 16256.26 | 180 / 180 | 99% | 54.41 | 426 / 430 |
lung | 99% | 1186.73 | 571 / 578 | 100% | 77.28 | 1153 / 1155 |
thymus | 99% | 1136.16 | 649 / 653 | 99% | 57.92 | 597 / 605 |
pancreas | 100% | 2256.38 | 327 / 328 | 97% | 47.84 | 173 / 178 |
kidney | 100% | 1568.12 | 89 / 89 | 96% | 45.10 | 867 / 901 |
skin | 100% | 2393.21 | 1808 / 1809 | 95% | 57.34 | 447 / 472 |
adrenal gland | 99% | 4449.31 | 255 / 258 | 83% | 60.37 | 190 / 230 |
liver | 86% | 644.43 | 195 / 226 | 79% | 25.51 | 322 / 406 |
brain | 74% | 722.83 | 1944 / 2642 | 52% | 16.21 | 366 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 83.07 | 29 / 29 |
spleen | 100% | 1000.12 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 109.81 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 31.50 | 1 / 1 |
adipose | 100% | 1178.68 | 1200 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1096.09 | 1320 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 78% | 28.78 | 62 / 80 |
peripheral blood | 64% | 1458.37 | 593 / 929 | 0% | 0 | 0 / 0 |
heart | 32% | 186.31 | 274 / 861 | 0% | 0 | 0 / 0 |
muscle | 2% | 9.41 | 16 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006139 | Biological process | nucleobase-containing compound metabolic process |
GO_0006015 | Biological process | 5-phosphoribose 1-diphosphate biosynthetic process |
GO_0006164 | Biological process | purine nucleotide biosynthetic process |
GO_0006098 | Biological process | pentose-phosphate shunt |
GO_0009156 | Biological process | ribonucleoside monophosphate biosynthetic process |
GO_0005829 | Cellular component | cytosol |
GO_0002189 | Cellular component | ribose phosphate diphosphokinase complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0004749 | Molecular function | ribose phosphate diphosphokinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0016301 | Molecular function | kinase activity |
Gene name | PRPS2 |
Protein name | Phosphoribosyl pyrophosphate synthetase 2 Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (PPRibP) (Phosphoribosyl pyrophosphate synthase II) (PRS-II) |
Synonyms | |
Description | FUNCTION: Catalyzes the synthesis of phosphoribosylpyrophosphate (PRPP) that is essential for nucleotide synthesis. |
Accessions | ENST00000461630.1 D3YTJ7 H7C540 P11908 A6NMS2 ENST00000398491.6 [P11908-2] ENST00000489404.5 ENST00000380663.7 ENST00000380668.10 [P11908-1] |